Lynne E. Becker is seeking a senior level position in corporate project research. She has over 10 years of experience managing multi-site clinical research projects, including experience in protocol development, site selection and training, patient recruitment, and ensuring regulatory compliance. She is skilled in data analysis, database management, and using technology like telemedicine to efficiently achieve project goals.
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
Best Practices for a Data-driven Approach to Test UtilizationViewics
Would you like to learn how data-driven interventions can improve laboratory test utilization in your organization? Would you like to hear about the impact that leading hospitals/health systems and managed care organizations have made through these interventions?
If so, you might be interested in this presentation by utilization management expert Dr. Michael Astion, Medical Director at the Department of Laboratories at Seattle Children’s Hospital and Clinical Professor of Laboratory Medicine at the University of Washington.
In this presentation, Dr. Astion discusses the current state of the misuse of laboratory testing in the United States and some of the interventions that are being implemented to improve it. He covers a number of common areas of unnecessary testing — from pure abuse to tests that could be useful but are ordered inappropriately.
You'll learn about:
• Two areas of laboratory testing where misordering of tests occur frequently
• Three interventions to improve the value of testing for patients
• The role of genetic counselors and other laboratory professionals in improving lab test ordering
• The national endeavor known as PLUGS, the Pediatric Laboratory Utilization Guidance Service
Impacting Recruitment from a Sponsor / CRO PerspectiveFraser Gibson
As presented at the SoCRA ( Society of Clinical Research Associates) Global Conference in October 2016 by Fraser Gibson.
This slideshow looks at the current state of patient recruitment in the clinical research industry. We then proposes a series of solutions that sponsors may considering implementing in order to positively impact the recruitment rates into their clinical trial.
Advantage Clinical provides online education and training in the clinical research industry. Visit www.advantage-clinical.com to learn more about our clinical research education and training courses.
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemViewics
The United States healthcare system has a serious infectious disease management problem. The antibiotic resistance crisis is widespread, serious, costly, and deadly. Delays in pathogen identification lead to poor clinical outcomes, including increased mortality risk. And, optimally managing outbreaks is critical to health systems whose reimbursement is tied to the health of a population, such as ACOs.
Eleanor Herriman, MD, MBA, Chief Medical Informatics Officer at Viewics led an informative panel discussion with industry leaders on the issues surrounding the infectious disease management crisis. Margret Oethinger, MD, Ph.D., Medical Director of Providence Health & Services, and Susan E. Sharp, Ph.D., DABMM, FAAM, Regional Director of Microbiology and the Molecular Infectious Disease Laboratories, Department of Pathology, Kaiser Permanente and President-Elect, American Society for Microbiology cover the current state of infectious disease management in the U.S., and what can be done to improve it.
You’ll learn about:
• The magnitude of the U.S. health system’s infectious disease management problem
• The most serious concerns and trends for healthcare institutions and communities across the nation
• The most promising solutions to health systems’ most urgent infectious disease management challenges
Using real-world evidence to investigate clinical research questionsKarin Verspoor
Adoption of electronic health records to document extensive clinical information brings with it the opportunity to utilise that information to support clinical research, and ultimately to support clinical decision making. In this talk, I discuss both these opportunities and the challenges that we face when working with real-world clinical data, and introduce some of the strategies that we are adopting to make this data more usable, and to extract more value from it. I specifically discuss the use of natural language processing to transform clinical documentation into structured data for this purpose.
Edm forum virtual brown bag presentationMarion Sills
EDM Forum Virtual Brown Bag Presentation 2013
Overview of the SAFTINet Project
For more information on SAFTINet, please see http://www.ucdenver.edu/academics/colleges/medicalschool/programs/outcomes/COHO/saftinet/Pages/default.aspx
Understand what healthcare analytics is.
Identify the 5-stage Analytics Program Lifecycle (APL).
Understand how data analytics can be used in healthcare.
Check it on Experfy: https://www.experfy.com/training/courses/introduction-to-healthcare-analytics.
Basic Study Recruitment and Regulatory Issues: Which Methods are Appropriate?CTSI at UCSF
Presentation by Laurie Herraiz, RD, CCRP in May 2012 at CHR sponsored workshop on UCSF Campus. Topics include, basics of regulatory and recruitment, iMedrRIS application instructions, waivers of consent/authorization for recruitment purposes, examples of approved recruitment materials, and common challenges to recruitment.
Development of the Gestational Diabetes Registry at CMDHB (New Zealand) using...Koray Atalag
This is the prezo I have at the Australasian Long-Term Conditions Conference in Auckland on 30 Jul 2014. Focus was on prevention and management of long term conditions and use of clinical registries has proven to be effective. This is a pilot project at a large healthcare provider organisation in Auckland (Counties Manukau District Health Board) where we used the full openEHR stack to build web based front end with the OceanEHR backend.
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
Best Practices for a Data-driven Approach to Test UtilizationViewics
Would you like to learn how data-driven interventions can improve laboratory test utilization in your organization? Would you like to hear about the impact that leading hospitals/health systems and managed care organizations have made through these interventions?
If so, you might be interested in this presentation by utilization management expert Dr. Michael Astion, Medical Director at the Department of Laboratories at Seattle Children’s Hospital and Clinical Professor of Laboratory Medicine at the University of Washington.
In this presentation, Dr. Astion discusses the current state of the misuse of laboratory testing in the United States and some of the interventions that are being implemented to improve it. He covers a number of common areas of unnecessary testing — from pure abuse to tests that could be useful but are ordered inappropriately.
You'll learn about:
• Two areas of laboratory testing where misordering of tests occur frequently
• Three interventions to improve the value of testing for patients
• The role of genetic counselors and other laboratory professionals in improving lab test ordering
• The national endeavor known as PLUGS, the Pediatric Laboratory Utilization Guidance Service
Impacting Recruitment from a Sponsor / CRO PerspectiveFraser Gibson
As presented at the SoCRA ( Society of Clinical Research Associates) Global Conference in October 2016 by Fraser Gibson.
This slideshow looks at the current state of patient recruitment in the clinical research industry. We then proposes a series of solutions that sponsors may considering implementing in order to positively impact the recruitment rates into their clinical trial.
Advantage Clinical provides online education and training in the clinical research industry. Visit www.advantage-clinical.com to learn more about our clinical research education and training courses.
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemViewics
The United States healthcare system has a serious infectious disease management problem. The antibiotic resistance crisis is widespread, serious, costly, and deadly. Delays in pathogen identification lead to poor clinical outcomes, including increased mortality risk. And, optimally managing outbreaks is critical to health systems whose reimbursement is tied to the health of a population, such as ACOs.
Eleanor Herriman, MD, MBA, Chief Medical Informatics Officer at Viewics led an informative panel discussion with industry leaders on the issues surrounding the infectious disease management crisis. Margret Oethinger, MD, Ph.D., Medical Director of Providence Health & Services, and Susan E. Sharp, Ph.D., DABMM, FAAM, Regional Director of Microbiology and the Molecular Infectious Disease Laboratories, Department of Pathology, Kaiser Permanente and President-Elect, American Society for Microbiology cover the current state of infectious disease management in the U.S., and what can be done to improve it.
You’ll learn about:
• The magnitude of the U.S. health system’s infectious disease management problem
• The most serious concerns and trends for healthcare institutions and communities across the nation
• The most promising solutions to health systems’ most urgent infectious disease management challenges
Using real-world evidence to investigate clinical research questionsKarin Verspoor
Adoption of electronic health records to document extensive clinical information brings with it the opportunity to utilise that information to support clinical research, and ultimately to support clinical decision making. In this talk, I discuss both these opportunities and the challenges that we face when working with real-world clinical data, and introduce some of the strategies that we are adopting to make this data more usable, and to extract more value from it. I specifically discuss the use of natural language processing to transform clinical documentation into structured data for this purpose.
Edm forum virtual brown bag presentationMarion Sills
EDM Forum Virtual Brown Bag Presentation 2013
Overview of the SAFTINet Project
For more information on SAFTINet, please see http://www.ucdenver.edu/academics/colleges/medicalschool/programs/outcomes/COHO/saftinet/Pages/default.aspx
Understand what healthcare analytics is.
Identify the 5-stage Analytics Program Lifecycle (APL).
Understand how data analytics can be used in healthcare.
Check it on Experfy: https://www.experfy.com/training/courses/introduction-to-healthcare-analytics.
Basic Study Recruitment and Regulatory Issues: Which Methods are Appropriate?CTSI at UCSF
Presentation by Laurie Herraiz, RD, CCRP in May 2012 at CHR sponsored workshop on UCSF Campus. Topics include, basics of regulatory and recruitment, iMedrRIS application instructions, waivers of consent/authorization for recruitment purposes, examples of approved recruitment materials, and common challenges to recruitment.
Development of the Gestational Diabetes Registry at CMDHB (New Zealand) using...Koray Atalag
This is the prezo I have at the Australasian Long-Term Conditions Conference in Auckland on 30 Jul 2014. Focus was on prevention and management of long term conditions and use of clinical registries has proven to be effective. This is a pilot project at a large healthcare provider organisation in Auckland (Counties Manukau District Health Board) where we used the full openEHR stack to build web based front end with the OceanEHR backend.
NER Public Health Digital Library ProjectElaine Martin
The New England Region's Public Health Digital Library Project was presented by Elaine Martin, DA, and Karen Dahlen. The project aims to build a digital public health library that will help make information resources, such as full-text journal articles, evidence-based guidelines, and systematic reviews available to public health professionals in all 50 U.S. states.
5th Annual Early Age Onset Colorectal Cancer Summit - Session II: Family History Ascertainment in the US - What Steps are Needed to Improve the Well Documented Less Than Optimal Status of this Situation?
NIH Research grants (R series) are an important funding mechanism for independent investigators as these awards offer the opportunity to head up major research projects.
In this presentation, Dr. Ian de Boer will leverage his experience from winning six different R awards to provide R series grant writing strategies. He explores: which R award is best for you; readiness and qualifications for independent support; formulating focused and solid research strategies; how to avoid common mistakes; tips for early investigators; and NIH expectations and grant requirements.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Evaluation of antidepressant activity of clitoris ternatea in animals
Becker, lynne resume mar2016
1. Lynne E. Becker, MSPH
lynne.e.becker@gmail.com
670 North Stiles Drive
Charleston, SC 29412 843 817-2530
Objective
A Senior Level Position in Corporate Project Research
Summary
Experienced in protocol development, execution and management in all phases of clinical research
Site Selection, Training and Patient Recruitment and Retention (local, national, and international)
Knowledgeable in multiple phases of telemedicine applications and systems
10 years of project management experience for multi-site projects and across platforms
IRB and IACUC project management experience
Ability to train administrative, study staff and scientific professionals in complex procedures
Experienced in all phases of federal regulatory requirements and reporting mandates
Employs telemedicine and telehealth technology to achieve goals efficiently
Efficient in data warehousing principles to maintain project lifecycle timelines
I am a Data Scientist with significant experience in project management. I blend my experiences in
epidemiology with computer analysis and statistical skills, to efficiently manage large-scale national and
international projects. I am skilled in interpreting data in a scientific manner for dissemination to clinicians as
well as for publications and business decisions for market expansion. I manage large data warehouses with
emphasis in data cleaning, visualization, and analysis. I am able to use my epidemiological and research
methodology experiences in all phases (I-IV) of protocol development to design experimental trials,
forecasting, modeling, employing statistical inference and other procedures for successful clinical studies.
Experience
Medical University of South Carolina, Charleston, SC 2011 - Present
International National Project Manager for a PECOURRI (Mar 2016-Present)
I am managing an International research trial for the orthopedics unit at the Medical University of South Carolina.
I am managing a 4 year, 14.4 million dollar, 26 site multi-national longitudinal pragmatic project for the
Medical University of South Carolina, funded through the PCORI Foundation in Washington, DC
Coordinate all correspondence for the fiscal sponsor and sites.
Recruited & assisted with the team selection of 26 medical facilities across U.S. to conduct study
Trained 66 national site staff in study objectives, methods, and reporting - 100+ persons
Developed patient profile; assisted in patient recruiting; developed patient collateral material
Designed master database tracking / reporting system; designed all forms and reports
Developed a patient engagement program as this is a primary focus of the project, patient centric outcome
assessments
Assisted the development of the central IRB development and eIRB process
Negotiated / monitor budgets with study sponsor, research sites, and data vendors
Created all study materials for training local and remote coordinators, via WebEx support and SOP manuals
Assure necessary ancillary vendors provide reliability, security and confidentiality
2. Lynne E. Becker, MSPH Page 2
National Project Manager for a Type 2 Diabetes Clinical Trial (Nov 2011-Mar 2016)
Manage with staff of 6 all aspects of all clinical research projects within the Weight Management Center.
Studies vary from $5M to $250k, Pilot Projects to Phase III clinical trials
Designed study definitions, objectives, methodologies, milestones and reporting (protocol)
Recruited / selected 16 medical facilities across U.S. to conduct study with patients
Trained 16 national site staff in study objectives, methods, and reporting - 40+ persons
Developed patient profile; assisted in patient recruiting; developed patient collateral material
Designed master database tracking / reporting system; designed all forms and reports
Monitor 16 sites for regulatory compliance of sponsor claims with Federal Trade Commission
Negotiated / monitor budgets with study sponsor, research sites, medical labs and data collection services
Assure necessary ancillary vendors provide reliability, security and confidentiality
United States Department of Commerce 2008 - 2011
National Oceanic and Atmospheric Administration (NOAA), Charleston, SC
IACUC Project Manager
Institutional Animal Care and Use Committee, as mandated by U.S. National Institute of Health Office of
Laboratory Animal Welfare (OLAW)
Developed / implemented first IACUC program for NOAA: program adopted globally
Edited protocols in accord with NOAA scientists and IACUC guidelines for statistical soundness and
research design methodologies
Designed database and reporting systems for tracking and submitting data to OLAW
Recruited / trained local IACUC members in protocol and animal research policies
Assisted in safety training, procedural inspections and program efficacy review
Select Health of South Carolina, Charleston, SC 2007 - 2009
Insurance company owned by AmeriHealth Mercy; focus is on those on Medicare, Medicaid and in poverty;
offers outreach programs intended to improve community health.
Senior Business Analyst / Program Manager
Created wellness database system; identifies / tracks patient improved health status based on reduction in
medications taken; presumed a result of community outreach programs
Analyzed accrued data; reported results to non-profit evaluation agency National Committee for Quality
Assurance (NCQA) / Healthcare Effectiveness Data and Information Set (HEDIS)
Created cost reporting system for specific case and disease management teams; objective to identify cost
cutting / expense containment areas against actual budget expenditures
Created member self- help portal to assist in treatment options and preventative measures
Member of Healthy Hoops Wellness Committee; fund raiser and outreach program activities
College of Charleston, Charleston, SC 2005 - 2008
Office of Research and Grants Administration
Compliance Program Manager - IRB and IACUC
(Institutional Review Board)
Managed human (IRB) / animal (IACUC) protocol (research project) approval and funding
Monitored annual protocol status reviews, modifications, new submissions, adverse events
Co-Chaired IRB / IACUC review committees and scientific community
Began an initiative to train 500+ scientists / students / committee members in workshops on compliance
with OLAW, USDA, Public Health Service, college provost and other agency regulations
Developed electronic signature input method greatly speeding data capture process
3. Lynne E. Becker, MSPH Page 3
Medical University of South Carolina, Charleston, SC 1993 - 2003
Director - Information / Telecommunication Technology 2000 - 2003
South Carolina Area Health Education Consortium
Managed data processing of 4 remote location $1M+ federally funded program; objective to bring quality
medical care closer to remote SC patients and continuing education to MDs
Re-engineered web site for interactive video conferencing to accommodate above goals
Developed / implemented customized physician / patient surveys utilizing optical character recognition
(OCR) / optical mark recognition (OMR); improved ease, accuracy and speed
Trained headquarters and remote staff in effective operation of system capabilities
Gathered / analyzed system data for reporting to appropriate federal / state agencies
Director of Clinical Trials - Hollings Cancer Center 1998 - 2001
Managed staff of 18 providing clinical trial service center for center’s scientific community; included data
managers, nurses, IRB / quality assurance staff and programmers (internal CRO)
Managed submissions, activities, logistics of 50 active / 150 long term follow-up protocols
Created database systems for work loads, patient calendars, budget analysis and reporting
Assisted Clinical Review Committee improving IRB / peer panel submission efficiency
Assured physician procedural compliance as member of Data Safety and Monitoring Board
Generated $500K+ net income annually from pharmaceutical companies in post marketing trials
Biostatistician / Data Analyst - Hollings Cancer Center 1996 - 1998
Participated in telemedicine test case development for U.S. Department of Defense, Office of Naval
Research and IBM; prove efficacy of transmitting shipboard medical data to onshore facility for processing,
thereby improve speed, expense and reduce onboard facility
Designed / tested all survey tools; coordinated patient recruitment / management
Created / authored video for community consumption to gain volunteer cooperation
Supervised data entry methods / personnel at local and remote locations; conducted analysis
Statistician / Data Manager - Institute of Psychiatry 1993 - 1996
Developed / implemented database system to verify / analyze protocol data on a multi-site research
project to establish baseline alcohol abuse for NIH
Assisted in coordination of 7 national research institutions
Assisted scientists in grant funding applications; wrote justifying statistical portions
Taught research fellows, nurses, graduate students grant design methodologies
Previous positions:
Alliance Pharmaceutical Corporation, San Diego, CA 1990 - 1992
Biostatistician / Regulatory Writer
IOPTEX Research, Inc. Azusa, CA 1987 - 1990
Clinical Program Manager
University of Southern California, Pasadena, CA 1986 - 1987
National Institute of Health Research Fellow - Children’s Cancer Study Group
Gerber Scientific Products, Hartford, CT 1985 - 1987
Graphics Instructor
Dun & Bradstreet, New York, NY 1984 - 1986
Analyst
4. Lynne E. Becker, MSPH Page 4
Education
Loma Linda University, Loma Linda, CA 1992
School of Public Health
Masters of Science Public Health - Biostatistics & Epidemiology
Russell Sage College, Troy, NY 1984
Bachelor of Arts - Mathematics and Computer Science
Publications
Effects on glucose control and weight of a modified commercial weight control program for people with Type 2
diabetes, ICE/ENDO International Conference, 2014.
(Note: Invited Featured poster accepted for interim results - embargoed until presentation.)
Body Image and Eating Restraining in Men, Nutrition, 1993.
Endophthalmitis Caused by the Coagulase-Negative Staphylococci; Disease Spectrum and Outcome,
Ophthalmology, 1992.
Endophthalmitis Caused by the Coagulase-Negative Staphylococci; Factors Influencing Presentation after Cataract
Surgery, Ophthalmology, 1992
Professional Associations
Featured Presenter at Cambridge Institute June 2015: Tablet Technology in Clinical Trials Mgt
Regulatory Affairs Professional Society (RAPS))
Association of Clinical Research Professionals (ACRP)
Society of Clinical Research Associates (SOCRA)
Public Responsibility in Medicine and Research (PRIMR)